Detail page

Knowledge Web

Person

Janaki Manoja Vinnakota

Biologin

Name	Janaki Manoja Vinnakota
Place	Vijayawada (Geburtsort) Deutschland
Profession	Biologin (characteristic profession)
Variant	Janaki M. Vinnakota
Related	Universitätsklinikum Freiburg. Klinik für Innere Medizin I
Further information	Dissertation 2022, Albert-Ludwigs-Universität Freiburg, Fakultät für Biologie
Record type	Person
GND-Identifier	1211052788
Record ID	1211052788
Involved in show all Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Janaki Manoja Vinnakota

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome

ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease

ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease

Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma

Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy

Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation